Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment

Background: Metformin has been reported to have an anti-tumorigenic impact against metastatic breast cancer (MBC) cells through several mechanisms. Its effect can be evaluated by using many variables such as the response rate (RR) as well as the progression-free survival (PFS). Materials and methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Essa, Nourhan M., Salem, Heba F., Elgendy, Marwa O., Gabr, A., Omran, Mervat M., Hassan, Nivin A., Tashkandi, Hanaa M., Harakeh, Steve, Boshra, Marian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572354/
https://www.ncbi.nlm.nih.gov/pubmed/36233373
http://dx.doi.org/10.3390/jcm11195505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572354/
https://www.ncbi.nlm.nih.gov/pubmed/36233373
http://dx.doi.org/10.3390/jcm11195505

Ejemplares similares